Safety Study of GRNOPC1 in Spinal Cord Injury
Trial ID or NCT#
NCT01217008
Status
NOT RECRUITING
Purpose
The purpose of the study is to evaluate the safety of GRNOPC1 administered at a single time-point between 7 and 14 days post injury, inclusive, to patients with neurologically complete spinal cord injuries (SCI).
Investigator(s)
Gary K. Steinberg, MD, PhD
View on ClinicalTrials.gov